Comparing the current results to its competitors, Processa Pharmaceuticals Inc reported Revenue decrease in the 2 quarter 2026 year on year by 0 %, despite the revenue increase by the most of its competitors of 6.58 %, recorded in the same quarter.
Processa Pharmaceuticals Inc , slower than the average decrease reported by the company's competitors of -2.21 %. recorded a net loss and most of the company's competitors saw a decline in earnings by -2.21 %
Processa Pharmaceuticals Inc 's Comment on Competition and Industry Peers
The company utilizes patents, trade secrets, proprietary know-how, and ongoing innovation to maintain its competitive position. It seeks exclusivity through FDA regulatory filings and protects its technology with confidentiality agreements, although these measures may not fully prevent unauthorized use or disclosure. The company holds an exclusive license agreement with Elion Oncology, Inc. to develop, manufacture, and commercialize PCS6422 globally. The competitive landscape includes numerous potential competitors with greater financial resources, more established market presence, and extensive expertise in research, development, manufacturing, clinical testing, regulatory approvals, reimbursement, and marketing. Industry mergers and acquisitions may concentrate resources among fewer competitors. Smaller or early-stage companies may also pose competition, particularly through collaborations with larger firms. Competitors also compete for qualified personnel, clinical trial sites, patient enrollment, and complementary technologies. Key competitive factors for the company's products, if approved, will include efficacy, safety, convenience, and price compared to other approved products used on- or off-label for unmet medical needs.
Publicly Traded Peers of Processa Pharmaceuticals Inc
Astec Industries Inc Share Performance
-0.92%
This Year
Astec Industries Inc
Profile
Astec Industries Inc operates as a diversified manufacturer of equipment and infrastructure solutions. The company primarily focuses on the production of equipment for asphalt road building, aggregate processing, energy, and water treatment. Through its various subsidiaries, Astec serves customers in the construction, mining, and energy industries, aiming to provide innovative solutions and high-quality equipment for their specific needs.
Redhill Biopharma Ltd is a specialty pharmaceutical company focused on improving patient care and developing innovative treatments. Their business model revolves around advancing the research and development of drug candidates in therapeutic areas with unmet medical needs. By seeking partnerships and leveraging their in-house expertise, they aim to bring these potential treatments to market for the benefit of patients worldwide.
Regeneron Pharmaceuticals Inc operates a business model centered on the discovery and commercialization of cutting-edge biopharmaceuticals, particularly in the fields of ophthalmology, oncology, immunology, and rare diseases. They leverage their strong research and development capabilities, including their proprietary technologies, to create innovative therapies that address unmet medical needs. Additionally, Regeneron forms strategic collaborations and partnerships to enhance their development pipeline and expand market access for their products.
Vertex Pharmaceuticals Incs business model centers on the research and development of innovative therapies, primarily targeting cystic fibrosis and other serious diseases. They emphasize collaboration with organizations, strategic partnerships, and robust investment in R&D to deliver transformative treatments to patients and enhance their quality of life.
Sources:
Processa Pharmaceuticals Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Processa Pharmaceuticals Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
